Israeli Pharma Firm Pays $519 Million to Settle FCPA Charges

Israeli firm Teva Pharmaceutical Industries, the world's largest generic drug manufacturer, and its wholly owned Russian subsidiary, Teva LLC (Teva Russia), agreed Dec. 22, 2016, to pay $519 million …

This item is available in full to subscribers.

Please log in to continue

Log in